The abstract is read at the publisher; the summary is JClub's.
Smooth muscle–specific inducible KCa3.1 knockout in Apoe-/- mice increases brachiocephalic artery plaque size and stenosis and reduces lumenal area after 15–40 weeks on a Western diet.
- Why it matters: Prior work shows KCa3.1 inhibition can limit atherosclerosis, but the specific contribution of KCa3.1 in smooth muscle cells versus other lesion cell types remained unclear.
- What they did: The authors created smooth muscle–specific inducible KCa3.1-/-; Apoe-/- mice and compared tamoxifen- versus vehicle-injected groups, assessing brachiocephalic artery lesions after 15 or 40 weeks on a Western diet, plus RNAseq at baseline and after 15 weeks.
- The result: Loss of smooth muscle KCa3.1 reduced smooth muscle and collagen content at 15 and 40 weeks while increasing macrophage content at 40 weeks, and baseline RNAseq showed mitochondrial/PPAR-dependent signaling changes that disappeared after 15 weeks on the diet.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.